1. Home
  2. MLAB vs TMCI Comparison

MLAB vs TMCI Comparison

Compare MLAB & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • TMCI
  • Stock Information
  • Founded
  • MLAB 1982
  • TMCI 2014
  • Country
  • MLAB United States
  • TMCI United States
  • Employees
  • MLAB N/A
  • TMCI N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MLAB Industrials
  • TMCI Health Care
  • Exchange
  • MLAB Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • MLAB 791.9M
  • TMCI 649.1M
  • IPO Year
  • MLAB N/A
  • TMCI 2021
  • Fundamental
  • Price
  • MLAB $141.70
  • TMCI $9.37
  • Analyst Decision
  • MLAB Hold
  • TMCI Hold
  • Analyst Count
  • MLAB 2
  • TMCI 8
  • Target Price
  • MLAB $140.00
  • TMCI $8.84
  • AVG Volume (30 Days)
  • MLAB 35.3K
  • TMCI 413.1K
  • Earning Date
  • MLAB 02-04-2025
  • TMCI 02-27-2025
  • Dividend Yield
  • MLAB 0.45%
  • TMCI N/A
  • EPS Growth
  • MLAB N/A
  • TMCI N/A
  • EPS
  • MLAB N/A
  • TMCI N/A
  • Revenue
  • MLAB $237,747,000.00
  • TMCI $202,861,000.00
  • Revenue This Year
  • MLAB $13.48
  • TMCI $13.27
  • Revenue Next Year
  • MLAB $4.74
  • TMCI $8.61
  • P/E Ratio
  • MLAB N/A
  • TMCI N/A
  • Revenue Growth
  • MLAB 11.68
  • TMCI 16.14
  • 52 Week Low
  • MLAB $83.68
  • TMCI $3.92
  • 52 Week High
  • MLAB $155.12
  • TMCI $14.82
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 49.71
  • TMCI 47.42
  • Support Level
  • MLAB $142.58
  • TMCI $9.69
  • Resistance Level
  • MLAB $152.03
  • TMCI $10.30
  • Average True Range (ATR)
  • MLAB 7.53
  • TMCI 0.45
  • MACD
  • MLAB -0.40
  • TMCI -0.16
  • Stochastic Oscillator
  • MLAB 40.67
  • TMCI 3.40

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Share on Social Networks: